CHOP recently launched a Bone and Soft Tissue Tumor Program, a collaboration between teams from Orthopedics and Oncology.

CHOP's revolutionary T-cell immunotherapy was featured at “Cellular Horizons: The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact,” an exclusive international event at the Vatican.

The Division of Genomic Diagnostics at Children’s Hospital of Philadelphia has launched AUDIOME, a comprehensive genetic test for the diagnosis of nonsyndromic hearing loss in children (NSHL).

Dr. Hakon Hakonarson will address a major conference in precision medicine at which experts review progress in applying DNA discovery to advancing human health.

Two cardiologists from Children’s Hospital of Philadelphia discuss the evolving guidelines from AHA/ACC over the past 30 years for children with anomalous aortic origin of a coronary artery (AAORCA) who want to participate in competitive sports.

The Children’s Oncology Group (COG) high risk acute lymphoblastic leukemia (HR ALL) TARGET Project is a large collaborative effort led by Stephen Hunger, MD.

Find updates about new CHOP programs dedicated to leukodystrophies and children entering foster care; Rheumatology access updates; and recent research related to concussions and distinguishing Lyme disease from septic arthritis.

CHOP researchers have identified a new gene that raises the risk of type 2 diabetes. The gene influences insulin sensitivity, and may lead to future treatments.

Local, national and international media outlets were once again inspired by Zion and his medical team. Check out the sampling of coverage that features Zion and his amazing story.

CHOP has chosen Monica Taylor Lotty as its new executive vice president and chief development officer, following an extensive national search.